SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
---|---|---|---|---|---|---|---|---|---|
18-Nov-24 7:20 PM View: | Rothenberg MacE Director | Tango Therapeutics, Inc. (TNGX) | 18-Nov-24 | Purchase | 10,000 | $3.78 | $37,800.00 | 47% 21.25K to 31.25K | |
18-Nov-24 7:20 PM View: | Rothenberg MacE Director | Tango Therapeutics, Inc. (TNGX) | 14-Nov-24 | Private Purchase | 10,000 | $3.62 | $36,200.00 | 89% 11.25K to 21.25K | |
17-Sep-24 4:48 PM View: | Third Rock Ventures Iv, L.P. 10% Owner | Tango Therapeutics, Inc. (TNGX) | 13-Sep-24 | Market Sale | 67,400 | $10.53 | $709,756.00 | (< 1%) 16.93M to 16.86M | 3% |
09-Sep-24 7:19 PM View: | Third Rock Ventures Iv, L.P. 10% Owner | Tango Therapeutics, Inc. (TNGX) | 05-Sep-24 | Private Sale | 75,000 | $11.56 | $867,135.00 | (< 1%) 17.0M to 16.93M | |
29-Aug-24 4:40 PM View: | Third Rock Ventures Iv, L.P. 10% Owner | Tango Therapeutics, Inc. (TNGX) | 27-Aug-24 | Private Sale | 25,000 | $11.55 | $288,665.00 | (< 1%) 17.2M to 17.18M | |
20-Aug-24 5:59 PM View: | Third Rock Ventures Iv, L.P. 10% Owner | Tango Therapeutics, Inc. (TNGX) | 19-Aug-24 | Market Sale | 150,000 | $10.09 | $1,513,920.00 | (< 1%) 17.35M to 17.2M | (1%) |
20-Aug-24 5:59 PM View: | Third Rock Ventures Iv, L.P. 10% Owner | Tango Therapeutics, Inc. (TNGX) | 16-Aug-24 | Market Sale | 135,000 | $9.79 | $1,321,450.00 | (< 1%) 17.49M to 17.35M | (4%) |
01-Aug-24 5:51 PM View: | Third Rock Ventures Iv, L.P. 10% Owner | Tango Therapeutics, Inc. (TNGX) | 01-Aug-24 | Market Sale | 40,000 | $9.80 | $392,000.00 | (< 1%) 17.53M to 17.49M | (4%) |
01-Aug-24 5:51 PM View: | Third Rock Ventures Iv, L.P. 10% Owner | Tango Therapeutics, Inc. (TNGX) | 31-Jul-24 | Market Sale | 100,000 | $9.93 | $993,380.00 | (< 1%) 17.63M to 17.53M | (3%) |
01-Aug-24 5:51 PM View: | Third Rock Ventures Iv, L.P. 10% Owner | Tango Therapeutics, Inc. (TNGX) | 30-Jul-24 | Market Sale | 95,000 | $9.80 | $931,114.00 | (< 1%) 17.72M to 17.63M | (4%) |
30-Jul-24 4:15 PM View: | Third Rock Ventures Iv, L.P. 10% Owner | Tango Therapeutics, Inc. (TNGX) | 26-Jul-24 | Market Sale | 50,000 | $9.84 | $491,950.00 | (< 1%) 17.77M to 17.72M | (4%) |
26-Jul-24 4:15 PM View: | Third Rock Ventures Iv, L.P. 10% Owner | Tango Therapeutics, Inc. (TNGX) | 25-Jul-24 | Market Sale | 100,599 | $9.87 | $992,771.00 | (< 1%) 17.87M to 17.77M | (3%) |
26-Jul-24 4:15 PM View: | Third Rock Ventures Iv, L.P. 10% Owner | Tango Therapeutics, Inc. (TNGX) | 24-Jul-24 | Market Sale | 200,000 | $9.82 | $1,963,160.00 | (1%) 18.07M to 17.87M | (4%) |
24-Jul-24 4:15 PM View: | Third Rock Ventures Iv, L.P. 10% Owner | Tango Therapeutics, Inc. (TNGX) | 23-Jul-24 | Market Sale | 125,000 | $9.79 | $1,223,350.00 | (< 1%) 18.2M to 18.07M | (4%) |
24-Jul-24 4:15 PM View: | Third Rock Ventures Iv, L.P. 10% Owner | Tango Therapeutics, Inc. (TNGX) | 22-Jul-24 | Market Sale | 262,740 | $9.78 | $2,570,100.00 | (1%) 18.46M to 18.2M | (4%) |
22-Jul-24 4:15 PM View: | Third Rock Ventures Iv, L.P. 10% Owner | Tango Therapeutics, Inc. (TNGX) | 18-Jul-24 | Market Sale | 191,490 | $9.81 | $1,878,480.00 | (1%) 18.65M to 18.46M | (4%) |
18-Jul-24 4:15 PM View: | Third Rock Ventures Iv, L.P. 10% Owner | Tango Therapeutics, Inc. (TNGX) | 17-Jul-24 | Market Sale | 550,171 | $9.79 | $5,386,340.00 | (3%) 19.2M to 18.65M | (4%) |
02-Jul-24 8:56 PM View: | Mva Investors, LLC | Tango Therapeutics, Inc. (TNGX) | 02-Jul-24 | Sale | 95,000 | $8.68 | $824,600.00 | (47%) 203.79K to 108.79K | |
02-Jul-24 8:56 PM View: | Mva Investors, LLC | Tango Therapeutics, Inc. (TNGX) | 01-Jul-24 | Sale | 110,731 | $8.87 | $982,184.00 | (35%) 314.52K to 203.79K | |
02-Jul-24 8:56 PM View: | Mva Investors, LLC | Tango Therapeutics, Inc. (TNGX) | 28-Jun-24 | Sale | 29,000 | $8.57 | $248,530.00 | (8%) 343.52K to 314.52K | |
07-Jun-24 9:14 PM View: | Mva Investors, LLC | Tango Therapeutics, Inc. (TNGX) | 07-Jun-24 | Sale | 77,000 | $6.88 | $529,760.00 | (18%) 425.52K to 348.52K | |
07-Jun-24 9:14 PM View: | Mva Investors, LLC | Tango Therapeutics, Inc. (TNGX) | 06-Jun-24 | Sale | 63,000 | $7.24 | $456,120.00 | (13%) 488.52K to 425.52K | |
07-Jun-24 5:13 PM View: | Ketchum John B Director | Tango Therapeutics, Inc. (TNGX) | 05-Jun-24 | Grant | 4,687 | -- | -- | 47% 10.0K to 14.69K | |
07-Jun-24 5:17 PM View: | Rothenberg MacE Director | Tango Therapeutics, Inc. (TNGX) | 05-Jun-24 | Grant | 6,250 | -- | -- | 125% 5.0K to 11.25K | |
07-Jun-24 5:21 PM View: | Peters Malte Director | Tango Therapeutics, Inc. (TNGX) | 05-Jun-24 | Grant | 6,250 | -- | -- | 125% 5.0K to 11.25K | |
07-Jun-24 5:11 PM View: | Borisy Alexis Director | Tango Therapeutics, Inc. (TNGX) | 05-Jun-24 | Grant | 6,250 | -- | -- | 125% 5.0K to 11.25K | |
07-Jun-24 5:16 PM View: | Calhoun Lesley Ann Director | Tango Therapeutics, Inc. (TNGX) | 05-Jun-24 | Sale (Planned) | 5,000 | $7.21 | $36,039.00 | 400% 1.25K to 6.25K | |
03-May-24 9:34 PM View: | Mva Investors, LLC | Tango Therapeutics, Inc. (TNGX) | 03-May-24 | Sale | 60,000 | $7.61 | $456,600.00 | (11%) 548.52K to 488.52K | |
03-May-24 9:34 PM View: | Mva Investors, LLC | Tango Therapeutics, Inc. (TNGX) | 02-May-24 | Sale | 75,000 | $7.56 | $567,000.00 | (12%) 623.52K to 548.52K | |
03-May-24 9:34 PM View: | Mva Investors, LLC | Tango Therapeutics, Inc. (TNGX) | 01-May-24 | Sale | 75,000 | $7.43 | $557,250.00 | (11%) 698.52K to 623.52K | |
21-Feb-24 5:52 PM View: | Third Rock Ventures Iv, L.P. 10% Owner | Tango Therapeutics, Inc. (TNGX) | 20-Feb-24 | Private Sale | 162,500 | $12.00 | $1,950,000.00 | (< 1%) 19.36M to 19.2M | |
08-Feb-24 9:08 PM View: | Beckman Daniella Chief Financial Officer | Tango Therapeutics, Inc. (TNGX) | 07-Feb-24 | Sale | 1,817 | $12.62 | $22,930.20 | (1%) 134.21K to 132.4K | |
08-Feb-24 9:04 PM View: | Crystal Adam See Remarks | Tango Therapeutics, Inc. (TNGX) | 07-Feb-24 | Sale | 4,083 | $12.62 | $51,526.60 | (3%) 123.56K to 119.48K | |
08-Feb-24 9:09 PM View: | Barry Douglas General Counsel | Tango Therapeutics, Inc. (TNGX) | 07-Feb-24 | Sale | 1,354 | $12.62 | $17,087.20 | (3%) 45.34K to 43.98K | |
08-Feb-24 9:14 PM View: | Weber Barbara Chief Executive Officer Director | Tango Therapeutics, Inc. (TNGX) | 07-Feb-24 | Sale | 4,457 | $12.62 | $56,246.40 | (< 1%) 1.54M to 1.54M | |
08-Feb-24 9:14 PM View: | Weber Barbara Chief Executive Officer Director | Tango Therapeutics, Inc. (TNGX) | 06-Feb-24 | Private Sale | 4,681 | $12.56 | $58,805.50 | (< 1%) 1.54M to 1.54M | |
08-Feb-24 9:08 PM View: | Beckman Daniella Chief Financial Officer | Tango Therapeutics, Inc. (TNGX) | 06-Feb-24 | Private Sale | 1,908 | $12.56 | $23,969.40 | (1%) 136.12K to 134.21K | |
08-Feb-24 9:04 PM View: | Crystal Adam See Remarks | Tango Therapeutics, Inc. (TNGX) | 06-Feb-24 | Private Sale | 4,288 | $12.56 | $53,868.40 | (3%) 127.85K to 123.56K | |
08-Feb-24 9:09 PM View: | Barry Douglas General Counsel | Tango Therapeutics, Inc. (TNGX) | 06-Feb-24 | Private Sale | 1,422 | $12.56 | $17,864.00 | (3%) 46.76K to 45.34K | |
05-Feb-24 4:21 PM View: | Weber Barbara Chief Executive Officer Director | Tango Therapeutics, Inc. (TNGX) | 01-Feb-24 | Grant | 87,168 | -- | -- | 100% 0 to 87.17K | |
05-Feb-24 4:22 PM View: | Crystal Adam See Remarks | Tango Therapeutics, Inc. (TNGX) | 01-Feb-24 | Grant | 46,599 | -- | -- | 100% 0 to 46.6K | |
05-Feb-24 4:27 PM View: | Beckman Daniella Chief Financial Officer | Tango Therapeutics, Inc. (TNGX) | 01-Feb-24 | Grant | 39,413 | -- | -- | 100% 0 to 39.41K | |
05-Feb-24 4:19 PM View: | Barry Douglas General Counsel | Tango Therapeutics, Inc. (TNGX) | 01-Feb-24 | Grant | 22,859 | -- | -- | 100% 0 to 22.86K | |
02-Nov-23 4:49 PM View: | Crystal Adam See Remarks | Tango Therapeutics, Inc. (TNGX) | 01-Nov-23 | Sale | 7,507 | $8.39 | $62,994.20 | (8%) 88.76K to 81.25K | |
17-Oct-23 6:04 PM View: | Boxer Capital, LLC | Tango Therapeutics, Inc. (TNGX) | 16-Oct-23 | Purchase | 500,000 | $6.84 | $3,420,000.00 | 3% 15.41M to 15.91M | |
17-Oct-23 6:04 PM View: | Boxer Capital, LLC | Tango Therapeutics, Inc. (TNGX) | 13-Oct-23 | Private Purchase | 750,000 | $7.07 | $5,302,500.00 | 5% 14.66M to 15.41M | |
11-Oct-23 9:22 PM View: | Boxer Capital, LLC | Tango Therapeutics, Inc. (TNGX) | 09-Oct-23 | Market Sale | 50,000 | $9.91 | $495,500.00 | (< 1%) 14.89M to 14.84M | (3%) |
11-Oct-23 9:22 PM View: | Boxer Capital, LLC | Tango Therapeutics, Inc. (TNGX) | 09-Oct-23 | Market Sale | 175,000 | $9.97 | $1,744,750.00 | (1%) 14.84M to 14.66M | (2%) |
31-Aug-23 4:07 PM View: | Ketchum John B Director | Tango Therapeutics, Inc. (TNGX) | 29-Aug-23 | Grant | 10,000 | -- | -- | 100% 0 to 10.0K | |
15-Aug-23 9:34 PM View: | Boxer Capital, LLC Director | Tango Therapeutics, Inc. (TNGX) | 11-Aug-23 | Private Purchase | 475,000 | $5.15 | $2,446,250.00 | 3% 14.41M to 14.89M |